122 related articles for article (PubMed ID: 528082)
1. In vitro lymphocyte reactivity to soluble tumor extracts in Sinclair melanoma swine.
Aultman MD; Hook RR
Int J Cancer; 1979 Nov; 24(5):673-8. PubMed ID: 528082
[No Abstract] [Full Text] [Related]
2. Humoral and cell-mediated immune response in patients with malignant melanoma. I. In vitro lymphocyte reactivity to PHA and antigens following immunization.
de Gast GC; The TH; Schraffordt Koops H; Huiges HA; Oldhoff J; Nieweg HO
Cancer; 1975 Oct; 36(4):1289-97. PubMed ID: 1175127
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated immune reactivity of Sinclair melanoma-bearing swine to 3 M KCl extracts of swine and human melanoma.
Hook RR; Hamby CV; Millikan LE; Berkelhammer J; Stills HF; Oxenhandler RW
Int J Cancer; 1983 May; 31(5):633-7. PubMed ID: 6852980
[TBL] [Abstract][Full Text] [Related]
4. Cell mediated immune response in miniature Sinclair swine bearing cutaneous melanomas.
Jones DH; Amoss MS
Can J Comp Med; 1982 Apr; 46(2):209-11. PubMed ID: 7093814
[TBL] [Abstract][Full Text] [Related]
5. [Immunology of melanoma].
Vanwijck R; Bernheim JL; Lejeune FJ
Acta Chir Belg; 1974 Mar; 73(2):135-88. PubMed ID: 4615541
[No Abstract] [Full Text] [Related]
6. Active specific and active non-specific immunotherapy in patients with malignant melanoma.
Kokoschka EM; Cerni C; Micksche M
Oncology; 1977; 34(5):229-33. PubMed ID: 917456
[TBL] [Abstract][Full Text] [Related]
7. Sensitisation of lymphocytes in vitro against human melanoma-associated antigens.
Golub SH; Morton DL
Nature; 1974 Sep; 251(5471):161-3. PubMed ID: 4421563
[No Abstract] [Full Text] [Related]
8. Human malignant melanoma antigenic properties of phenol water extracts.
Suter L; Tilkorn H; Kövary PM
Arch Dermatol Res; 1979 Feb; 264(1):37-47. PubMed ID: 443860
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of cellular immunity to tumor-specific antigens of malignant melanoma in hamsters by inhibition of macrophage migration.
Henderson WR; Fukuyama K; Epstein WL; Spitler LE
J Invest Dermatol; 1972 Apr; 58(4):229-32. PubMed ID: 5020976
[No Abstract] [Full Text] [Related]
10. Comparative evaluation of lymphocyte subpopulations, delayed cutaneous hypersensitivity reactions and autoantibody formation in cancer patients.
Pichler WJ; Stingl G; Wagner G; Micksche M; Neumann H; Knapp W
Osterr Z Onkol; 1977 Nov; 4(5-6):110-7. PubMed ID: 202907
[No Abstract] [Full Text] [Related]
11. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
[TBL] [Abstract][Full Text] [Related]
12. Immunodiagnostics of malignant disease. VI. Electrophoretic mobility test (EMT) in malignant melanoma.
Douwes FR; Spellmann HJ; Mross K; Wolfrum DI
Oncology; 1978; 35(4):163-7. PubMed ID: 81476
[TBL] [Abstract][Full Text] [Related]
13. Association of uveal melanocyte destruction in melanoma-bearing swine with large granular lymphocyte cells.
Richerson JT; Burns RP; Misfeldt ML
Invest Ophthalmol Vis Sci; 1989 Dec; 30(12):2455-60. PubMed ID: 2592158
[TBL] [Abstract][Full Text] [Related]
14. Analysis of soluble melanoma cell membrane antigens in metastatic cells of various organs and further studies of antigens present in primary melanoma.
Hollinshead AC
Cancer; 1975 Oct; 36(4):1282-8. PubMed ID: 51680
[TBL] [Abstract][Full Text] [Related]
15. In vitro lymphocyte stimulation by a soluble antigen from malignant melanoma.
Jehn UW; Nathanson L; Schwartz RS; Skinner M
N Engl J Med; 1970 Aug; 283(7):329-33. PubMed ID: 4193645
[No Abstract] [Full Text] [Related]
16. [Immunological analysis of melanoma specific antigen. (I). In-vitro induction of melanoma-antigen specific killer T lymphocytes in primary immune response].
Wakabayashi S; Taniguchi M; Tomioka H; Okamoto S
Nihon Hifuka Gakkai Zasshi; 1983 Dec; 93(14):1469-76. PubMed ID: 6676498
[No Abstract] [Full Text] [Related]
17. Sinclair miniature swine: an animal model of human melanoma.
Misfeldt ML; Grimm DR
Vet Immunol Immunopathol; 1994 Oct; 43(1-3):167-75. PubMed ID: 7856049
[TBL] [Abstract][Full Text] [Related]
18. [Immunologic reaction-readiness in malignant melanoma].
Bickhardt R; Kunze J
Z Hautkr; 1974 Apr; 49(8):315-33. PubMed ID: 4599330
[No Abstract] [Full Text] [Related]
19. [Lymphocyte reactivity against fetal antigens during the growth and regression of experimental tumors].
Schlott B; Gryschek G; Albrecht S; Pasternak G
Biomed Biochim Acta; 1985; 44(5):805-11. PubMed ID: 4062925
[TBL] [Abstract][Full Text] [Related]
20. Generation of cytotoxic lymphocytes against human tumor cells in vitro by various soluble microbial extracts.
Sharma B; Brunda MJ; Minden P
J Natl Cancer Inst; 1979 Aug; 63(2):341-6. PubMed ID: 222929
[No Abstract] [Full Text] [Related]
[Next] [New Search]
